Form 4 Tracker
Candel Therapeutics, Inc.
CADL

30 insider filings · Latest: Sep 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 15, 2025Jan 15 1:30 PMTak Paul Peter
Proposed Sale
19,970$7.84$156.6K—

View →

Jan 8, 2025Jan 8 1:29 PMTyagarajan Seshu
Proposed Sale
14,297$8.35$119.4K—

View →

Jan 8, 2025Jan 8 1:28 PMTak Paul Peter
Proposed Sale
20,811$8.35$173.8K—

View →

Jan 8, 2025Jan 8 1:28 PMNichols William Garrett
Proposed Sale
10,614$8.35$88.6K—

View →

Jan 8, 2025Jan 8 1:27 PMBarone Francesca
Proposed Sale
13,440$8.35$112.2K—

View →

Jan 8, 2025Jan 8 1:27 PMSchoch Charles
Proposed Sale
9,801$8.35$81.8K—

View →

Nov 29, 2024Nov 29 2:17 PMTyagarajan Seshu
Proposed Sale
18,548$4.95$91.8K—

View →

Nov 29, 2024Nov 29 2:15 PMTak Paul Peter
Proposed Sale
44,433$4.95$219.9K—

View →

Nov 29, 2024Nov 29 2:13 PMNichols William Garrett
Proposed Sale
12,675$4.95$62.7K—

View →

Nov 29, 2024Nov 29 2:12 PMBarone Francesca
Proposed Sale
20,085$4.95$99.4K—

View →

Sep 23, 2024Sep 23 9:16 PMAguilar-Cordova Estuardo
Proposed Sale
28,480$7.00$199.4K—

View →

Sep 13, 2024Sep 13 9:53 PMAguilar-Cordova Estuardo
Proposed Sale
28,840$6.50$187.5K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 31, 2026Apr 2 9:08 PMNicoletta LoggiaDirector
Grant/Award
779$4.90779(D)

View →

Jan 26, 2026Jan 28 10:04 PMSeshu TyagarajanChief Technology Officer
Grant/Award
154,000$6.01154,000(D)

View →

Jan 26, 2026Jan 28 10:03 PMWilliam Garrett NicholsChief Medical Officer
Grant/Award
136,500$6.01136,500(D)

View →

Jan 26, 2026Jan 28 10:02 PMCharles SchochChief Financial Officer
Grant/Award
232,000$6.01232,000(D)

View →

Jan 26, 2026Jan 28 10:01 PMPaul Peter TakDirector, Chief Executive Officer
Grant/Award
629,000$6.01629,000(D)

View →

Jan 26, 2026Jan 28 10:00 PMFrancesca BaroneChief Scientific Officer
Grant/Award
232,000$6.01232,000(D)

View →

← Previous

Page 2 of 2